Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Clovis Oncology Prevails in European Patent Proceedings Related to Rubraca
Clovis Oncology Prevails in European Patent Proceedings Related to Rubraca
Clovis Oncology Prevails in European Patent Proceedings Related to Rubraca
Submitted by
admin
on December 4, 2018 - 9:36am
Source:
CP Wire
News Tags:
Clovis Oncology
Europe
Rubraca
Headline:
Clovis Oncology Prevails in European Patent Proceedings Related to Rubraca
snippet:
Ruling will confirm European regulatory exclusivity for Rubraca until at least 2028
Clovis also recently received a patent for using Rubraca in high doses to treat cancer in the US
Do Not Allow Advertisers to Use My Personal information
